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Abstract
Background: Inorganic arsenic is a major water pollutant and a known human carcinogen that has
a suppressive influence on spermatogenesis and androgenesis in male reproductive system.
However, the actual molecular events resulting in male reproductive dysfunctions from exposure
to arsenic remain unclear. In this context, we evaluated the mode of action of chronic oral
exposure of sodium arsenite on hypothalamo-pituitary- testicular activities in mature male albino
rats.
Methods: The effect of chronic oral exposure to sodium arsenite (5 mg/kg body weight/day) via
drinking water without or with hCG (5 I.U./kg body weight/day) and oestradiol (25 micrograms
oestradiol 3-benzoate suspended in 0.25 ml olive oil/rat/day) co-treatments for 6 days a week for
4 weeks (about the duration of two spermatogenic cycle) was evaluated in adult male rats. Changes
in paired testicular weights, quantitative study of different varieties of germ cells at stage VII of
spermatogenic cycle, epididymal sperm count, circulatory concentrations of hormones (LH, FSH,
testosterone and corticosterone), testicular activities of delta 5, 3beta-hydroxysteroid
dehydrogenase (delta 5, 3beta-HSD), 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD),
sorbitol dehydrogenase (SDH), acid phosphatase (ACP), alkaline phosphatase (ALP), and lactate
dehydrogenase (LDH), as well as the levels of biogenic amines (dopamine, noradrenaline and 5-
hydroxytryptamine (5-HT)) in the hypothalamus and pituitary were monitored in this study.
Hormones were assayed by radioimmuno- assay or enzyme- linked immunosorbent assay and the
enzymes were estimated after spectrophotometry as well as the biogenic amines by HPLC
electrochemistry.
Results: Sodium arsenite treatment resulted in: decreased paired testicular weights; epididymal
sperm count; plasma LH, FSH, testosterone and testicular testosterone concentrations; and
increased plasma concentration of corticosterone. Testicular enzymes such as delta 5, 3 beta-HSD,
17 beta-HSD, and sorbitol dehydrogenase (SDH) were significantly decreased, but those of acid
phosphatase (ACP), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) were
significantly increased. A decrease in dopamine or an increase in noradrenaline and 5-HT in
hypothalamus and pituitary were also noted after arsenic exposure. Histological evaluation
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revealed extensive degeneration of different varieties of germ cells at stage VII of spermatogenic
cycle in arsenic exposed rats. Administration of human chorionic gonadotrophin (hCG) along with
sodium arsenite partially prevented the degeneration of germ cells and enhanced paired testicular
weights, epididymal sperm count, plasma and intratesticular testosterone concentrations, activities
of delta 5, 3beta-HSD, 17 beta-HSD and sorbitol dehydrogenase along with diminution in the
activities of ACP, ALP and LDH. Since many of the observed arsenic effects could be enhanced by
oestradiol, it is suggested that arsenic might somehow acts through an estrogenic mode of action.
Conclusion: The results indicate that arsenic causes testicular toxicity by germ cell degeneration
and inhibits androgen production in adult male rats probably by affecting pituitary gonadotrophins.
Estradiol treatment has been associated with similar effects on pituitary testicular axis supporting
the hypothesis that arsenite might somehow act through an estrogenic mode of action.
Background
Arsenic, as trivalent arsenite (As3+) or pentavalent arsenate
(As5+), is naturally occurring and ubiquitously present in
the environment. Arsenical compounds are environmen-
tal toxins with multiple effects in animal and human pop-
ulations [1,2]. Humans are exposed to arsenic mainly
through oral or inhalation routs. Oral exposure occurs via
consumption of contaminated water, food, and drugs,
and exposure can be life long. Occupational exposure, on
the other hand, occurs mainly through inhalation via
nonferrous ore smelting, semiconductor and glass manu-
facturing, or power generation by the burning of arsenic
contaminated coal [1]. The main source of environmental
arsenic exposure in most populations is the drinking
water in which inorganic form of arsenic predominate
[3,4]. Clearly assessing the risk from, exposure to inor-
ganic arsenic in water supplies is a key issue facing the sci-
entific community. High levels of arsenic in the drinking
water can be found in areas within many countries includ-
ing Taiwan, China, Chile, Mexico, Argentina, Thailand,
Finland, Hungary and Bangladesh [4-6], but it is becom-
ing evident that even the low levels of arsenic typically
found in India may pose a significant health risk to the
humans [5,6]. The frequent uses of arsenic as herbicides,
insecticides, rodenticides, food preservatives, and byprod-
uct of used fossil fuel [7] those are challenging the aquatic
environment. Although, chronic dermal toxicity, nephro-
toxicity, and skin cancer all occurs with arsenic exposure
[6]. Arsenic is a multi-site carcinogen in humans, causing
tumors in a variety of tissues including lung, skin, and
bladder [2,6]. Other studies indicate that the kidney, liver,
uterus and prostate may also be target sites of arsenic car-
cinogenesis in humans [6,8]. Recently arsenic intoxication
in experimental animals has been associated with hepatic
tumors [8], the inhibition of ovarian steroidogenic func-
tion and gonadotrophins secretion [9]. Arsenic exposure
also has been associated with an elevation of adrenocorti-
cal steroidogenesis and plasma corticosterone level [10],
as well as with severe metabolic disorders such as diabetes
in humans [11]. Acute arsenic exposure may cause gas-
trointestinal tract disorders [12], whereas chronic expo-
sure may exert degenerative, inflammatory, and
neoplastic changes of the respiratory, heamatopoetic, car-
diovascular, and nervous systems [13]. The effect of
sodium arsenite on male reproductive system is not well
established, although there are some reports in which
arsenite intoxication is associated with spermatotoxicity
[2,14], inhibition of testicular androgenesis and reduction
of the weight of the testes and accessory sex organs [15] in
experimental animals. However, the actual molecular
events resulting in male reproductive toxicity from expo-
sure of inorganic arsenic remain unclear. There are several
possible mechanisms for the anti-gonadal activities of dif-
ferent chemicals. They may exert a direct inhibitory action
on the testis; they may affect pituitary causing changes in
gonadotrophins concentrations and thus spermatogenic
impairment. hCG has a stimulatory effect on the animals
own pituitary to secrete FSH, while possessing LH like
activity itself [16]. In the present study, changes in enzy-
matic and hormonal milieu after arsenic with or without
hCG treatment were investigated. Repeated arsenic expo-
sure was associated with proliferative pre-neoplastic
lesions of the testis [8]. Estrogen treatment has also been
associated with proliferative lesions of the testis, disrupts
spermatogenesis and inhibits androgen production along
with suppressed gonadotrophins secretion from pituitary
[17,18]. So, in this study we like to investigate whether the
arsenic may act through an estrogenic mode of action on
hypothalamo-pituitary- testicular axis.
Materials and methods
Animal selection and care
Thirty, Sprague-Dawley (90 days of age), adult male
albino rats, weighing 200–250 gm were obtained from
the animal facility of the Institute. The animals were
housed single per cage under controlled condition of
ambient temperature (22 ± 2°C), humidity (60 ± 5%) and
photoperiod controlled room (light: dark: 14 h: 10 h)
with free access to standard laboratory food (formulated
& prepared in our laboratory) and water ad libitum. The
NIH Guide for the Care and Use of Laboratory Animals (NIH
publication No. 85 -23 revised 1985: US Department ofReproductive Biology and Endocrinology 2006, 4:9 http://www.rbej.com/content/4/1/9
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Health, Education and Welfare, Bethesda, Maryland,
USA) was followed throughout the experimental dura-
tion. The experimental protocol also met the National
Guidelines on the Proper Care and Use of Animals in Labora-
tory Research (Indian Science Academy, New Delhi, India)
and was duly approved by the Animal Ethics Committee of
the Institute.
Drug treatments
Sodium arsenite were obtained from Sigma Chemical Co.
(St. Louis, MO). All the animals were divided equally into
5 groups, with 6 animals per group and their initial body
weight were recorded along with a record of their daily
water consumption (about 10–12 ml/ day). Animals of
each group treated as follows. Group-1 (control rats)
orally received 10 ml of arsenic free distilled water as a
vehicle. Group-2 (arsenic-treated rats) was given orally 10
ml of water containing sodium arsenite at the dose of 5
mg per kg body weight per day. Group-3 (hCG supple-
mented, arsenic-treated rats) received in addition to oral
exposure of arsenic, subcutaneous injection of hCG at a
dose of 5 I.U./kg body weight/day. Group-4 (oestradiol
treated rats) received intramuscular injection of 25 µg
oestradiol 3-benzoate (Sigma Chemical Co., St. Louis,
MO), suspended in 0.25 ml olive oil/rat/day. Group-5
(oestradiol supplemented, arsenic-treated rats) received in
addition to oral exposure of arsenic, intramuscular injec-
tion of 25 µg oestradiol 3-benzoate suspended in 0.25 ml
olive oil/rat/day. All the treatments were continued for 6
days a week for 4 weeks (about the duration of two sper-
matogenic cycle). The selection of arsenic dose and proce-
dure of administration were based on the prior study
[17,19]. The arsenic dose is somehow higher the levels
found in drinking water in wide areas of India and other
countries where this trace element is present in the range
above the admissible limit of 0.01 ppm, according to
World Health Organization [5,9]. The doses of hCG and
oestradiol were also chosen on the basis of previous stud-
ies [16,17].
Animal sacrifice, collection of blood, brain and 
reproductive organs
At 1 day after the last day of treatment, all the animals
were sacrificed under light ether aesthesia within 8:00 and
10:00 h to avoid any diurnal fluctuation in the concentra-
tions of hormones and neurotransmitters. Care was also
taken not to increase in ether inhalation, to prevent any
interference with neurotransmitters. Body weight was
recorded before and after the treatment. Blood was col-
lected from each animal from dorsal aorta using
heparinized syringe (23 gauge needle). Plasma samples
were separated by centrifugation frozen and stored at -
20°C until all the samples had been collected for the
determination of the different hormonal parameters. The
paired testes, epididymis, pituitary and hypothalamus
were dissected out quickly and washed in 0.9 % (w/v)
cold normal saline, pat dried and the wet weight taken in
an electrical monopan balance. One of the testis was fixed
in Bouin,s fixative for histological evaluation and the
other testis was used for the enzyme assays.
Quantitative study of spermatogenesis
The testis was fixed in Bouin's fixative and embedded in
paraffin wax. Sections of 5 µm thickness were taken from
the mid portion of each testis and stained with periodic
acid Schiff (PAS)-hematoxylin and examined under a light
microscope. Quantitative study of spermatogenesis was
carried out by counting the relative number of each variety
of germ cells at stage VII of the seminiferous cycle, i.e.
type-A spermatogonia (Asg), preleptotine spermatocytes
(pLSc), mid pachytene spermatocytes (mPSc) and stage 7
spermatids (7Sd), according to the method of Leblond
and Clermont [20] and modified by Clermont and Mor-
gentaler [21]. The nuclei of different germ cells (except
step 19 spermatids which can not be enumerated pre-
cisely) were counted in 20 round tubules in rat. All the
counts (crude counts) of the germ cells were corrected for
differences in the nuclear diameter by the formula of: true
count = (crude count × section thickness)/(section thick-
ness - nuclear diameter of germ cell) [17]. The nuclear
diameter of each variety of germ cell was measured with a
Leitz micrometer. The possibility of variable tubular
shrinkage in the sections of both arsenic and vehicle
injected groups were eliminated by the index of tubular
shrinkage which was obtained from the average number
of Sertoli cell nuclei containing prominent nucleoli in the
sections of the treated rats divided by that of the controls
[21]. Stage VII spermatogenesis was analyzed because this
stage is highly susceptible to testosterone deficiency [22]
and also reflects the final stages of spermatid maturation
and thus provides evidence of spermatogenesis as a whole
[23].
Epididymal sperm count
Sperms were collected from an equal length of the caudae
of the excised epididymis of each rat by flushing with
same volume (10 ml) of suspension medium containing
140 mmol NaCl, 0.3 mmol Kcl, 0.8 mmol Na2HPO4, 0.2
mmol KH2PO4 and 1.5 mmol D-glucose (pH adjusted to
7.3 by adding 0.1 (N) NaOH) (E Merck). Collected sam-
ple was centrifuged at 100 × g for 2 min, and the precipi-
tate part was re-suspended in 10 ml of fresh suspension
medium. A fraction of suspension (100 µl) was mixed
with an equal volume of 1% Trypan blue in the same
medium, and numbers of sperms were counted in four
chambers (used for counting of white blood cells) of the
hemocytometer slide [24]. At this concentration of Trypan
blue (0.5%), the dye was completely excluded by intact
sperms, which appeared bright and colorless, but taken up
by dead and damaged sperms, which showed blue headsReproductive Biology and Endocrinology 2006, 4:9 http://www.rbej.com/content/4/1/9
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[25]. The sperms number was expressed per ml of suspen-
sion.
Assay of plasma LH, and FSH concentrations
The LH, and FSH concentrations in the plasma were meas-
ured using a double antibody radio-immuno-assay (RIA).
The plasma concentrations of LH and FSH were measured
according to the standard methods [26], with reagents
supplied by the Rat Pituitary Distribution Programme and
NIDDK (National Institute of Diabetes and Digestive Kid-
ney Diseases, Bethesda, MD, USA). Highly purified rat LH
(rLH-I-4) and rat FSH (rFSH-I-8) were iodinated with 1
mCi  125I (Bhaba Atomic Research Centre, Mumbai,
India), and with freshly prepared chloramine T (Sigma,
St.Louis, MO, USA) [27]. Goat antirabbit γ globulin was
used as the second antibody (Indo-Medicine, TX, USA).
NIDDK- rLH-RP-3 was used as a standard and NIDDK-
anti- rLH-S-5 was used for the LH assay. The limit of the
detection of LH was 0.05 ng at 80 %. For the FSH, NIDDK-
rFSH – RP-2 was used as a standard and NIDDK- anti-
rFSH – S-11 was used for the assay. The limit of the detec-
tion of FSH was 0.04 ng at 98 %. All the samples were
assayed on the same day to avoid the inter assay variation.
Intra assay coefficient of variation of LH and FSH assays
were 3.5 %.
Assay of plasma and intra- testicular testosterone 
concentrations
The testis was homogenized in 0.5 ml of water using
Teflon homogenizer that would be fitted into a microfuge
tube chilled in ice. Each sample was centrifuged at 10 000
× g for 10 min. The supernatant was removed, frozen, and
stored until the hormone assay [28]. Plasma and intra tes-
ticular concentrations of testosterone was measured with
commercially available kit (IBL, Hamburg, Germany), fol-
lowing the immunoenzymatic method in ELISA reader
(Merck, Japan) and according to the standard protocol
given by National Institute of Health and Family Welfare
(NIHFW, New Delhi, India) [29]. Horseradish peroxidase
was used as an enzyme-labeled antigen that made a com-
petition with unlabelled antigen for binding with a lim-
ited number of antibody sites on the micro- plates (solid
phase). Each testosterone concentration was calculated
from a standard curve with 5 standards. The absorbance of
standard and sample was monitored against the blank at
450 nm. The cross-reaction of the testosterone antibody to
dehydrotestosterone was 10% and intra-run precision had
a coefficient of variation of 6.2%. All the samples were
included in a single assay. The assay validated in respect to
correctness of the data in our laboratory was 98%.
Estimation of plasma concentration of corticosterone
Plasma concentration of corticosterone was measured by
spectroflurometrically (F-3010, Hitachi, Japan) according
to the method of Glic et al. [30] and modified by Silber
[31]. The fluorescence was measured at 463 nm (excita-
tion) and 518-nm (emission) by setting the instrument at
a spectroflurometric reading 80, with a standard corticos-
terone (Sigma) solution (1.6 µg/ml). A minimum of 1.6
µg corticosterone/100 ml plasma can be measured by this
method. The concentration of corticosterone was
expressed as µg/100 ml of plasma.
Assay of testicular key androgenic enzyme activities
The testicular ∆5, 3β-HSD activity was measured according
to the method of Talalay [32]. The testicular tissue of each
animal was homogenized in 15% spectroscopic grade
glycerol (BDH, Mumbai, India) containing 5 mmol potas-
sium phosphate (Loba, Mumbai, India) and 1 mmol
EDTA (Organon, Calcutta, India.) at a tissue concentra-
tion of 100 mg/ml. The homogenizing mixture was centri-
fuged at 10,000 × g for 30 min at 4°C. The supernatant (1
ml) was mixed with 1 ml of 100 µmol sodium pyrophos-
phate buffer (pH 8.9) and 30 µg of dehydroepiendroster-
one (Sigma) in 40 µl of ethanol and 960 µl of 25% BSA
(Sigma), making the incubation mixture a total of 3 ml.
The enzyme activity was measured after addition of 0.5
µmol of NAD (Sigma) to the tissue supernatant mixture in
a U2000 spectrophotometer (Hitachi, Japan) cuvette at
340 nm against a blank (without NAD). One unit of
Table 1: Testicular weights, quantitative analysis of spermatogenesis at stage VII and epididymal sperm counts in different 
experimental groups of adult male rats.
Treatment Paired testicular 
weight (g)
Spermatogenesis at stage VII Epididymal sperm 
count (no/ml)
ASg pLSc mPSc 7Sd
Control 2.31 ± 0.11 1.32 ± 0.21 18.62 ± 2.12 22.16 ± 1.62 64.30 ± 2.54 10260 ± 1410
Arsenic 1.74 ± 0.08* 0.65 ± 0.08* 10.54 ± 1.25* 12.20 ± 0.76* 30.28 ± 2.15* 6350 ± 308*
Arsenic + hCG 2.10 ± 0.05 1.48 ± 0.16 15.16 ± 1.82* 18.62 ± 0.64* 46.84 ± 3.24* 8940 ± 246*
Oestradiol 1.87 ± 0.06* 0.72 ± 0.12* 12.10 ± 1.12* 14.52 ± 0.42* 32.46 ± 1.31* 7105 ± 415*
Arsenic + Oestradiol 1.65 ± 0.09* 0.42 ± 0.05** 10.14 ± 1.21* 10.56 ± 1.32* 25.65 ± 1.42** 5120 ± 314*
Each value represents mean ± SE, n = 12. (ANOVA followed by multiple comparison two-tail t-tests, * p < 0.01, ** p < 0.001 as compared with 
respective control). Asg = spermatogonia-A, pLSc = preleptotine spermatocytes, mPSc = midpachytene spermatoeytes, 7Sd = stage 7 spermatids.Reproductive Biology and Endocrinology 2006, 4:9 http://www.rbej.com/content/4/1/9
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enzyme activity is the amount causing a change in absorb-
ence of 0.001/min at 340 nm.
The activity of testicular 17β-HSD was measured bio-
chemically [33] using the same supernatant prepared for
the assay of ∆5, 3β-HSD (above). The supernatant (1 ml)
was mixed with 1 ml of 440 µmol sodium pyrophosphate
buffer (pH 10.2), 40 µl of ethanol containing 0.3 µmol of
testosterone (Sigma) and 960 µl of 25% BSA (Sigma),
making the incubation mixture a total of 3 ml. The
enzyme activity was measured after addition of 1.1 µmol
NAD (Sigma) to the tissue supernatant mixture in a
U2000 spectrophotometer cuvette at 340 nm against a
blank (without NAD). One unit of enzyme activity is
equivalent to a change in absorbance of 0.001/min at 340
nm.
Assay of testicular acid phosphatase (ACP) and alkaline 
phosphatase(ALP) activities
The activity of testicular acid phosphatase was measured
following the standard method of Vanha-Perttula and
Nikkanen [34]. Testicular tissue was homogenized in 0.02
mol Tris HCl buffer, pH 7.5, at a tissue concentration of
10 mg/ml. 0.25 ml of a tissue homogenate was added in
a centrifuge tube containing 1 ml buffer (1.0 ml p- nitro-
phenol phosphate (PNPP) in 0.1 mol acetate buffer, pH
5.0). The mixture was incubated at 37°C for 30 min in a
water bath. Then the reaction was terminated by addition
of 0.1 ml 0.1 mol NaOH. The assay was based on the for-
mation of p- nitrophenol (PNP) in the hydrolysis of
PNPP. The activity was measured spectrophotometrically
at 420 nm using U2000 spectrophotometer. The concen-
tration of the sample was obtained from a standard curve
and expressed as µg of PNP liberated/ mg of tissue/ hr. For
determination of alkaline phosphatase the same homoge-
nizing media was used and the tissue concentration was
also same. 0.25 ml of a tissue homogenate was added in a
centrifuge tube containing 1 ml buffer (1 mmol PNPP in
1 mol Tris buffer, pH- 8.0). The mixture was incubated at
37°C for 30 min in a water bath. Then the reaction was
terminated by addition of 0.1 ml 0.1 mol NaOH. The
assay was based on the formation of PNP in the hydrolysis
of PNPP. The activity was measured spectrophotometri-
cally at 420 nm using U2000 spectrophotometer. The
concentration of the sample was obtained from a stand-
ard curve and expressed as µg of PNP liberated/ mg of tis-
sue/ hr [35].
Assay of testicular lactate dehydrogenase (LDH) and 
sorbitol dehydrogenase (SDH) activities
Testicular lactate dehydrogenase and sorbitol dehydroge-
nase activities were measured using the kits purchased
from Sigma Chemical Co. Testicular tissue was homoge-
nized in ice-cold 0.1 mol Tris EDTA buffer, pH 8.0 at a tis-
sue concentration of 10 mg/ml and then the
homogenizing mixture was centrifuged at 10,000 × g for
Testicular androgenic key enzyme activities, plasma and intra-testicular testosterone concentrations in control and different  experimental rats Figure 1
Testicular androgenic key enzyme activities, plasma and intra-testicular testosterone concentrations in control and different 
experimental rats. Data as mean + SE, n = 12, ANOVA followed by multiple comparison two- tail t- test (* p < 0.01, ** p < 
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30 min at 4°C. The supernatant was used for these
enzymes estimation. The LDH assay is based on the inter-
conversion of lactate and pyruvate and the SDH assay is
based on inter- conversion of Fructose and Sorbitol. Dur-
ing the reduction of pyruvate or fructose, an equimolar
amount of NADH is oxidized to NAD. The oxidation of
NADH results in a decrease in absorbance at 340 nm. The
rate of decrease of absorbance at 340 nm is directly pro-
portional to LDH or SDH activity in the sample, where
one unit of LDH or SDH activity is defined as 0.1 µmol of
substrate transformed/ minute at pH 7.6 at 25°C.
Estimation of neurotransmitters by HPLC
Pituitary and hypothalamus were weighted and sonicated
in 0.1 mol ice-cold perchloric acid/ lit containing 0.05%
EDTA. They were centrifuged at 10 000 × g for 10 min at
4°C and 10 µl of the supernatant was injected directly
into an HPLC system (Waters, Milford, MA) to determine
noradrenaline, dopamine and 5 HT according to the
method of Mohanakumar et al. [36]. The HPLC system
was equipped with a Universal injector, electrochemical
detector (460, Waters) and an ion-pair, Ultrasphere RP
analytical column (4.6 cm × 25 cm) with 5 µm particle
size (Beckmann, Fullerton, CA). The mobile phase con-
tained 8.65 mmol haptane sulphonic acid/ lit, 0.27 mmol
EDTA/ lit, 13% (v/v) acetonitrile, 0.4–0.45% (v/v) tri-
ethylamine and 0.20–0.25% (v/v) phosphoric acid. The
flow rate was 0.7 ml/min and the electro- detection was
performed at 0.74 V. The data were collected and inte-
grated in a Waters 745B data module. The peak heights
were measured and compared with authentic samples.
Results are presented as pmole/ mg fresh tissue and are
uncorrected values.
Statistical analysis
Results of the experiment were expressed as mean and
standard error of mean of different groups. The differences
between the mean values were evaluated by ANOVA fol-
lowed by multiple student's t- test [37]. The values for p <
0.01 were considered significant. Accordingly, a statistical
software package (SPSS) was used.
Results
Food consumption and body growth and relative organ 
weight
No differences in food consumption were seen in any of
the group of animals throughout the experimental sched-
ule. In all the treated groups, the body weight was not sig-
Plasma LH, FSH and corticosterone concentrations in control and different experimental rats Figure 2
Plasma LH, FSH and corticosterone concentrations in control and different experimental rats. Data as mean + SE, n = 12, 
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nificantly different from that of controls. The paired
testicular weights were significantly (p < 0.01) decreased
after arsenic or oestradiol treatments with respect to con-
trol indicating the testicular atrophy and damage. Co-
administration of hCG and arsenic restored this relative
organ weights towards control level. Co- administration
of oestradiol with arsenic showed more diminution in
this parameter in comparison to the controls (Table 1).
Effect on spermatogenesis
Quantitative study of spermatogenesis at stage VII
revealed detrimental effect of sodium arsenite treatment.
A significant reduction in the numbers of Asg, pLSc, mPSc
and 7Sd at stage VII of the seminiferous epithelium cycle
was observed after arsenic or oestradiol treatment when
compared to the controls. Co- administration of hCG and
arsenic increased the numbers of Asg, pLSc, mPSc and 7Sd
in comparison with arsenic- treated rats but a significant
reduction in the numbers of pLSc and mPSc was still
observed when compared with corresponding vehicle
injected controls. Administration of hCG prevented the
degeneration of 7Sd, although the count showed a lower
value when compared with vehicle injected controls. Fur-
thermore, the inhibitory effect of arsenic on spermatogen-
esis was enhanced by co- administration of oestradiol and
arsenic, as the degeneration in different generations of
germ cells was more drastic in this group with respect to
the group of animals treated with only arsenic (group-2).
Chronic exposure to sodium arsenite as well as oestradiol
resulted in a testicular damage, which showed reduction
in the number of germ cells from the seminiferous tubules
(Table 1).
Effect on epididymal sperm count
Sperm counts also revealed a significant (p < 0.01) reduc-
tion in the number of spermatozoa after both sodium
arsenite or oestradiol treatment when compared with
respective vehicle treated rats. Co- administration of hCG
and arsenic enhanced the number of epididymal sperma-
tozoids in comparison with arsenic-treated rats, though
the number did not reach the control level. Moreover, the
co- administration of oestradiol and arsenic enhanced the
antispermatogenic effect observed in rats treated only
with arsenic (group-2) or oestradiol (group-4) (Table 1).
Effect on testicular ∆5, 3β-HSD, 17β-HSD and SDH 
activities
Testicular ∆5, 3β-HSD and 17β-HSD are the key enzymes
for testosterone biosynthesis. The inhibitory responses
from sodium arsenite or oestradiol treatments were noted
in testicular ∆5, 3β-HSD or 17β-HSD or SDH activities.
The activities of ∆5, 3β-HSD, 17β-HSD and SDH in testic-
ular tissue were decreased significantly (p < 0.01) in both
the arsenic or oestradiol treated groups in comparison to
the vehicle control group. Moreover, co- administration of
hCG and arsenic restored these enzyme activities to the
control level. Co- administration of oestradiol and arsenic
enhanced the inhibitory responses on these testicular
enzyme activities observed in rats treated only with
arsenic (group2) or oestradiol (group 4) (Figure 1&3).
Effect on plasma concentrations of LH and FSH
Chronic arsenic or oestrdiol treatment significantly (p <
0.01) diminished the plasma LH and FSH concentrations.
Moreover, the co- administration of arsenic and oestradiol
revealed greater diminution in these hormone concentra-
tions observed in rats treated only with arsenic (group-2)
or oestradiol (group-4)(Figure 2).
Effect on plasma testosterone, corticosterone and 
intratesticular testosterone concentrations
Chronic exposure of sodium arsenite or oestradiol signif-
icantly (p < 0.01) decreased plasma and intratesticular tes-
tosterone concentrations. Co- administration of hCG and
arsenic increased the testicular testosterone and plasma
testosterone concentrations above those of the vehicle
injected control rats. Furthermore, the inhibitory effect
arsenic on this hormone concentration was enhanced by
co-administration of oestradiol with arsenic (group-5)
(Figure 1). There was a significant elevation in plasma
concentrations of corticosterone at any of the group
treated with arsenic or oestradiol in comparison to the
vehicle control group, though there was no significant dif-
ference in this hormone level in both the group of animals
that treated with only oestradiol or in combined treat-
ment of oestradiol and sodium arsenite. After co- admin-
istration of hCG and arsenic significantly diminished this
hormone concentration in comparison with arsenic-
treated rats but still greater than the control level (Figure
2).
Effect on testicular ACP, ALP, and LDH activities
The testicular activities of ACP, ALP and LDH were signif-
icantly (p < 0.01) increased after sodium arsenite or
oestradiol treatment in comparison to the vehicle control,
which reflects the testicular degeneration and cytotoxicity.
Co- administration of hCG and arsenic significantly
decreased these enzyme activities to the control level indi-
cating significant protection of germinal epithelium from
arsenic toxicity. Moreover, co- administration of oestra-
diol and arsenic revealed more elevation in these enzyme
activities in respect to the rats exposed to only with arsenic
(Figure 3).
Effect on neurotransmitters in hypothalamus and pituitary
Chronic oral sodium arsenite treatment resulted in a sig-
nificant decrease in dopamine and also a significant
increase in noradrenaline and 5-HT in both the hypotha-
lamus and pituitary (p < 0.01). These findings may indi-
cate the effect of arsenic on hypothalamo- pituitary axisReproductive Biology and Endocrinology 2006, 4:9 http://www.rbej.com/content/4/1/9
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through the modulation in the levels of brain neurotrans-
mitters by the stimulation of adrenergic and serotonergic
neurons or by inhibition of dopaminargic neuronal activ-
ities. Oestradiol treatment associated with the effects sim-
ilar to those induced by arsenic exposure. Moreover, the
co-administration with oestradiol and arsenic enhanced
the effects observed in rats treated only with arsenic
(group-2) (Figure 4a&4b).
Discussion
This study is first to show that chronic oral exposure of a
known environmental toxicant and human carcinogen,
arsenic, to adult male rats can alter reproductive functions
by decreasing the paired testicular mass, inhibiting testic-
ular androgenesis and decreasing concentrations of testo-
sterone and gonadotrophins along with increasing
adrenocortical activity. Paired testicular mass, a valuable
index of reproductive toxicity in male animals [38]
decreased in arsenic-treated animals and this decrease in
testicular mass was consistent with elimination of germ
cells [39]. Similar effects were also observed after treat-
ment with oestradiol alone or in combination with
arsenic. This antigonadal activity of oestradiol is in agree-
ment with the previous findings [18,40-43].
Testicular steroidogenic events, ∆5, 3β-HSD and 17β-HSD
play a key regulatory role, as these are the prime enzymes
in testicular androgenesis [23,44]. The diminution in
these enzymes by sodium arsenite treatment in our study
is in agreement with the findings of others, where arsenic
treatment was associated with the inhibition of testicular
androgenesis [15]. A dose-dependent decrease in plasma
and intratesticular concentrations of testosterone in
arsenic-treated rats may occur due to the inhibition of
these testicular androgenic enzymes activities, because
these enzymes are responsible for the regulation of testo-
sterone biosynthesis [23,45]. Moreover, the inhibition of
testicular androgenic enzymes in arsenic-treated rats may
be a result of low plasma levels of LH as this is a prime reg-
ulator of testicular androgenic enzymes activities [46,47].
In the present study, the spermatogenic disorder has been
reflected by the diminution in the number of different
generations of germ cells at stage VII of spermatogenic
cycle. These findings also corroborated with the previous
findings with arsenic in testis [15]. The inhibition in sper-
Testicular acid phosphatase, alkaline phosphatase, lactate dyhydrogenase and sorbitol dehydrogenase enzymes activities in con- trol and different experimental mature male rats Figure 3
Testicular acid phosphatase, alkaline phosphatase, lactate dyhydrogenase and sorbitol dehydrogenase enzymes activities in con-
trol and different experimental mature male rats. Data as mean + SE, n = 12, ANOVA followed by multiple comparison two- 
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matogenesis is may be due to low level of gonadotrophins
i.e. LH and FSH [48]. LH and FSH are required for quanti-
tatively normal spermatogenesis in pubertal rats [22,49].
The reduction of LH and FSH and consequent reduction
in testosterone production may therefore, be held respon-
sible for the arsenic induced changes in spermatogenesis.
This prediction for low plasma concentration of LH, FSH
and testosterone in arsenic-treated rats are consistent with
our results when plasma concentrations of LH, FSH and
testosterone have been decreased in treated rats in a dose-
dependent manner. Moreover, the reduction in the
number of Asg in arsenic-treated rats is possibly due to the
low level of FSH, as FSH inhibits the normal degeneration
of Asg and reduced FSH secretion may promotes Asg
degeneration [15,48]. Besides this, the germ cell degener-
ation by arsenic treatment is may be due to low intrates-
ticular concentrations of testosterone, as high level of
testosterone in testis is essential for normal spermatogen-
esis as well as for the maintenance of structural morphol-
ogy and normal physiology of seminiferous tubule
[50,51]. However the maturation of mPSc and 7Sd are tes-
tosterone dependent [48]. The reduction in the number of
mPSc and 7Sd following sodium arsenite treatment is due
to diminution in testosterone production. In experimen-
tal circumstances in which the intratesticular testosterone
concentration is reduced a significant germ cell death is
seen [52]. Testosterone is required for the attachment of
different generations of germ cells in seminiferous tubules
and therefore low level of intratesticular testosterone may
lead to detachment of germ cells from seminiferous epi-
thelium and may initiate germ cell apoptosis [53]. The
decreases in plasma testosterone concentrations may be
explained by the fact that the arsenic treatment causes a
decrease in plasma LH concentrations. In male rats, circu-
lating LH is responsible for maintaining normal plasma
testosterone concentrations [54]. The possibility of low
plasma level of gonadotrophins in this experiment may
be due to elevated secretion of glucocorticoids from adre-
nal gland as the high level of corticosterone also observed
in arsenic-treated animals. Moreover, arsenic activates the
stress signal pathway, the hypophysial- adrenocortical
axis and increased the secretion of ACTH from pituitary
[55]. The elevation of plasma levels of corticosterone,
which may suppress the sensitivity of gonadotroph cells
to GnRH and therefore may, prevents gonadotrophin
secretion [56]. The high levels of ACTH and corticosterone
also directly suppress testosterone production and secre-
tion by decreasing the testicular LH receptor [57] resulting
the reduction of spermatogenesis and epididymal sperm
count. The diminution in the epididymal sperm count in
arsenic-treated animals is due to the lower concentrations
of testosterone as the sperm production in testis and mat-
uration in epididymis is under the control of testosterone
[51]. Moreover, the increased activity of testicular acid
phosphatase and alkaline phosphatase in arsenic-treated
rats also reflects testicular degeneration, which may likely
be a consequence of suppressed testosterone and indica-
tive of lytic activity [58]. The activities of SDH and LDH in
testicular tissue are associated with the maturation of the
germinal epithelial layer of seminiferous tubule [14,59].
The activity of SDH increased markedly through out the
maturation of germ cells and is reported to decrease dur-
ing the depletion of germ cells [59]. Moreover, the activity
of this enzyme is regulated by testosterone and the dimi-
nution in this enzyme activity after arsenic exposure is due
to the decreased production of testosterone [60]. LDH is
reported to be present in higher amounts in the testis of
newborn rats and its activity declines with the develop-
ment of the testis. The increase in activity of LDH and
decrease in that of SDH observed in treated animals sug-
gest that this chemical exposure causes deterioration of
germinal epithelium [14,59,60]. Since the body weight
gain was not altered significantly in arsenic-treated rats in
comparison to controls. The deleterious effect of arsenic
on the male reproductive system may be due to the toxic
effect of arsenic itself on this particular system but not to
the health of the animals. Sodium arsenite induced dimi-
nution in plasma gonadotrophins may be due to the low
level of dopamine and elevated levels of noradrenaline
and 5-HT in hypothalamus and pituitary as these cata-
cholamines are the important regulators for gonado-
trophins secretion and synthesis [61]. However, the
diminution in the level of dopamine by arsenic treatment
caused the suppressed secretion of gonadotrophins as
dopamine has the stimulatory effect on gonadotrophins
secretion [19]. Increases in noradrenaline and 5-HT and
decrease in dopamine in hypothalamus and pituitary
indicate that the effect of the arsenic can be potentiated in
an environment in which steroid concentrations are high.
Co- administration of hCG in arsenic-treated rats resulted
a significant protection in testicular ∆5, 3β-HSD and 17β-
HSD activities, plasma and intratesticular testosterone to
the control along with increased total sperm count. The
protection of steroidogenesis in arsenic-treated animals
by hCG is due to the stimulatory effects of hCG on ster-
oidogenesis [62,63]. However, in this experiment, admin-
istration of hCG along with arsenic partially prevented the
degeneration of 7Sd but failed to restored spermatogene-
sis quantitatively. Although hCG failed to restore the
number of spermatocytes and spermatids, but the num-
bers of Asg were significantly increased compared with
that of vehicle control. Though the effect of hCG on Asg at
stage VII of the seminiferous cycle in adult rats is not clear
from this experiment but the initiation and maintenance
of spermatogenesis require LH and FSH in pre-pubertal
and pubertal rats [48] and hCG has a stimulatory effect on
the animals own pituitary to secrete FSH, while possessing
LH like activity itself [16,64]. LH stimulates Leydig cells to
produce testosterone within the testis. Intratesticular tes-Reproductive Biology and Endocrinology 2006, 4:9 http://www.rbej.com/content/4/1/9
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a. Levels of noradrenaline and 5HT in hypothalamus and pituitary in control and different experimental groups of mature male  albino rats Figure 4
a. Levels of noradrenaline and 5HT in hypothalamus and pituitary in control and different experimental groups of mature male 
albino rats. Data as mean + SE, n = 12, ANOVA followed by multiple comparison two- tail t- test. (* p < 0.01, ** p < 0.001 as 
compared with respective control.) b. The levels of dopamine in hypothalamus and pituitary in control and different experi-
mental groups of mature male albino rats. Data as mean + SE, n = 12, ANOVA followed by multiple comparison two- tail t- 
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tosterone is an absolute prerequisite for normal sperma-
togenesis [65]. FSH is also vital for normal testicular
function and is necessary for quantitatively normal sper-
matogenesis [66]. Moreover, hCG maintains the baseline
levels of intratesticular testosterone in gonadotrophins
withdrawal from exogeneous testosterone administration
[63]. The hCG acts as a LH and stimulated the Leydig cells
to produce testosterone and that maintains the normal
spermatogenesis after gonadotrophin suppression
[62,63]. The restoration of the activities of SDH, LDH,
ACP, and ALP in hCG co- administration may be due to
the significant protection of germ cells from arsenic
induced degeneration. However, the direct detrimental
action of arsenic on germ cells can't be ruled out since
administration of hCG along with arsenic treatment failed
to restore quantitatively the number of all varieties of
germ cells at stage VII of the seminiferous cycle.
The spermatogenic degeneration with arsenic treatment in
the present work could also be consistent with an estrogen
related mechanism. It is quite clear from this experiment
that chronic oestradiol treatment in adult rat can induce
the same spermatogenic degeneration as induced by
arsenic treatment. Moreover, the antispermatogenic
effects of arsenic could be enhanced by oestradiol co-
administration in arsenic-treated animals. It is widely
accepted that oestradiol treatment mimics the effects of
hypophysectomy in the testis, due to gonadotrophins and
testosterone suppression [17,18,67]. Oestradiol also sup-
pressed the transcription of gonadotrophin genes [68]. In
our study, oestradiol treatment resulted more than 75%
suppression of LH, FSH and testosterone concentrations,
respectively; that is its effect on germ cells degeneration
should be equivalent to other gonadotrophin suppressing
treatments [17,42,43]. Moreover, oestradiol exposure has
been shown to decrease Leydig cell volume and impair the
levels of mRNA and protein of important enzymes of ster-
oidogenesis [69,70] that is consistent with our result
where the key steroidogenic enzymes were diminished
after oestradiol treatment. Oestradiol treatment resulted
severe degeneration of germ cells at stage VII of seminifer-
ous epithelium cycle. Earlier morphological studies
showed that withdrawal of either gonadotrophins [67] or
testosterone [52] leads to a marked increase in this type of
cell death mainly at stage VII. It has been reported that
germ cell apoptosis occurs at several stages of the cycle
after either gonadotrophin [71] or testosterone [72] dep-
rivation. Blanco- Rodriguez and Martinez-Garcia [18] also
showed that oestradiol treatment caused germ cell apop-
tosis along with suppressed the gonadotrophin and testo-
sterone concentrations in rat.
Several arsenic-treated animals showed reproductive tract
abnormalities including gonadotrophins and androgen
suppression along with germ cell degeneration in testes,
effects similar to those induced by estrogenic agonists,
such as di-ethylstilbestrol, methoxychlor and tamoxifen
[42]. Further study, demonstrated that the enhanced
expression of estrogen receptors (ERs) and various ER-
associated gene products were evident in arsenic induced
testicular lesions [8] suggesting that arsenate may exhibit
the estrogenic properties.
Conclusion
From the present study, it may be suggested that sodium
arsenite treatment impairs male reproductive systems. It
appears, therefore, that arsenic treatment produces degen-
erative changes in the germ cells and inhibits androgen
production acting primarily at the level of pituitary to
inhibit the release of LH and FSH, that is partially pro-
tected by hCG co- administration. Estradiol treatment has
been associated with similar effects on pituitary testicular
axis and also co- treatment of oestradiol with arsenic
could enhance these effects supporting the hypothesis
that arsenite might somehow act through an estrogenic
mode of action. However, the possible action of arsenic as
an environmental estrogen deserves additional study.
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